维普期刊资源整合服务平台（V6.5）

66篇 您的检索式：作者名="Durrington P"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Can measurement of apolipoprotein B replace the lipid profile in the follow-up of patients with lipoprotein disorders? 显示文摘	DURRINGTON P N	2002	Clin Chem2002，48，3：	1
2	Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study 显示文摘	MACKNESS B DURRINGTON P MCELDUFF P	2003	Circulation2003，107，22：	1
3	Paraoxonase:biochemistry,genetics and relationship to plasma lipoproteins显示文摘	MACKNESS M I MACKNESS B DURRINGTON P N	1996	Curr Opin Lipidol1996，7，2：	1
4	Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein显示文摘	MACKNESS M I ARROL S DURRINGTON P N	1991	FEBS Lett1991，286，12：	1
5	Low paraoxonase activity predicts coronary events in the caerphilly prospective study显示文摘	Mackness B Durrington P McElduff P	2003	Circulation2003，107，22：	1
6	Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDStrial显示文摘	Colhoun HM Betteridge DJ Durrington P	2011	Diabetes2011，60，23：	1
7	Primary prevention of cardiovascular disease with atorvastain in type 2 diabetes in the Collaborative Atorvastain Diabetes Study( CARDS ) : Multicentre randomised placebo-controlled trial显示文摘	Colhoun H M Betteridge D J Durrington P N	2004	Lancet2004，364，9345：	1
8	Clinical aspects of hyperlipidaemia显示文摘	Durrington F N Miller J P	1994	Br J Hosp Med1994，23，：	1
9	Dyslipidaemia显示文摘	Durrington P	2003	Lancet2003，362，9385：	1
10	Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study(CARDS):multicentre randomized placebo-controlled trial显示文摘	Colhoun H M Betteridge D J Durrington P N	2004	Lancet2004，364，：	1
11	Squalene synthase inhibitors : clinical pharmacology and eholesterol-lowering potential显示文摘	Charhon-Menys V Durrington P N	2007	Drugs2007，67，1：	1
12	Paraoxonase and atherosclerosis显示文摘	DURRINGTON P N MACKNESS B MACKNESS M I	2001	Arterioscler Thromb Vasc Biod2001，21，4：	1
13	Paraoxonase and susceptibility to organophosphorus poisoning in farmESR dipping sheep 显示文摘	Mackness B Durrington P Povey A	2003	Pharmacogenetics2003，13，：	1
14	Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with Type 2 diabetes:an analysis from the CARDS trial显示文摘	Colhoun HM Betteridge DJ Durrington P	2011	Diabetes2011，60，9：	1
15	Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study 显示文摘	Mackness B Durrington P McEtduff P	2003	Circulation2003，107，22：	1
16	Paraoxonase (PON1) polymorphisms in farmers attributing ill health to sheep dip 显示文摘	Cherry N Mackness M Durrington P	2002	Lancet2002，359，9308：	1
17	HDL in risk prediction and its direct and indirect involvement in atherogenesis 显示文摘	Durrington P	2002	Atherosclerosis2002，3，4：	1
18	Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep 显示文摘	Mackness B Durrington P Povey A	2003	Pharmacogenetics2003，13，2：	1
19	Primary pre- vention of cardiovascular disease with atorvastatin in type 2 dia- betes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial显示文摘	Colhoun H M Betteridge D J Durrington P N	2004	Lancet2004，364，9435：	1
20	Human cholesterol metabolism and therapeutic molecules 显示文摘	CHARLTON M V DURRINGTON P N	2008	Experimental Physiology2008，93，1：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示